10-Year registry launches to test new heart Valve's staying power
NCT ID NCT06953206
First seen Apr 01, 2026 · Last updated Apr 24, 2026 · Updated 4 times
Summary
This study will follow 500 adults with severe aortic stenosis who receive a SAPIEN 3 Ultra Resilia valve during a minimally invasive procedure called TAVR. Researchers will track how well the valve works and how safe it is over 10 years. The goal is to understand the valve's long-term durability and performance.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Heart and Diabetes Center North Rhine-Westphalia
Bad Oeynhausen, North Rhine-Westphalia, 32545, Germany
Conditions
Explore the condition pages connected to this study.